Navigation Links
Mirena IUD Lawsuit Filings Exceed 920 in New Jersey Litigation, Bernstein Liebhard LLP Reports
Date:7/28/2014

New York, New York (PRWEB) July 28, 2014

Mirena IUD lawsuits (http://www.drugbot.com/mirena-iud/lawsuit/) that allege the long-acting birth control device caused some users to suffer serious injuries after it spontaneously migrated from its proper position in the uterus continue to mount in U.S. courts, Bernstein Liebhard LLP reports. According to a new case list issued last month in New Jersey, at least 924 Mirena lawsuits involving such allegations are pending in a multicounty litigation underway in Bergen County Superior Court. Some 148 claims have been filed in the proceeding since the Court issued a previous case list on July 8th, which recorded 776 filings. (In Re: Mirena Litigation; Case No. 297)

“Our Firm is representing numerous Mirena lawsuit clients in the New Jersey litigation, and we continue to receive inquiries from women who were allegedly injured by this IUD on a regular basis. We are not surprised that the number of filings now exceeds 900,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Mirena lawsuit evaluations to women who were seriously harmed, allegedly due to spontaneous migration of the IUD.

Mirena Lawsuits
The Mirena IUD is a long-acting contraceptive device that was first approved by the U.S. Food & Drug Administration (FDA) in 2000. It is inserted directly into the uterus by a healthcare provider, where it releases a synthetic progesterone for up to five years. In 2009, its approved uses were expanded to include the treatment of heavy menstrual bleeding in women who wish to use an IUD for birth control. In December 2009, the FDA also issued a warning letter to Bayer Healthcare Pharmaceuticals after finding that one of its Mirena promotions overstated the IUD’s benefits and downplayed its risks.

According to court documents, all of the Mirena IUD lawsuits pending in the New Jersey litigation allege that the device spontaneously migrated from its proper position in the uterus, despite having been correctly implanted by a healthcare professional. Plaintiffs claim that this occurrence led to a number of serious Mirena complications, including uterine perforations, scarring, adhesions and infertility, which in many cases required emergency treatment and surgical intervention.

Court records indicate that in addition to the claims pending in New Jersey, an additional 612 Mirena lawsuits involving similar allegations have been filed in a federal multicounty litigation now underway in U.S. District Court, Southern District of New York. (In re: Mirena IUD Products Liability Litigation, MDL No. 2434)

Alleged victims of serious Mirena complications related to spontaneous IUD migration may be entitled to compensation for medical bills, lost wages, pain and suffering and more. To learn more about the process for filing a Mirena lawsuit, please visit Bernstein Liebhard LLP’s website, or the Firm's Facebook page: https://www.facebook.com/mirenalawsuithelp. For a free and confidential Mirena case review, please call 800-511-5092.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.drugbot.com/
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/miren-iud-lawsuit/mirena-complications/prweb12051530.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Announces Alternative to Mirena IUD May Be Available Soon
2. DrugRisk Announces Updated Information on Mirena Lawsuits
3. Bernstein Liebhard LLP Launches Mirena IUD Lawsuit Website Providing Information on Side Effects, Growing Litigation
4. d’Oliveira & Associates Releases Mirena IUD Infographic Describing Bayer’s Deceptive Mirena Simple Style Campaign
5. d’Oliveira & Associates Issues Webpage With Current Information On Mirena IUD Lawsuits
6. The Law Firm of d'Oliveira & Associates Now Offers a No Win - No Fee Promise in Mirena IUD Cases
7. Drug Center Adds News on Mirena Lawsuits: Bayer Fighting Move to Federal Court
8. DrugRisk Update: Mirena Maker Asks to Keep Lawsuits With Local Court, Judge
9. Mirena Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on New Mirena IUD Side Effects Study
10. DrugRisks Update: Federal Court Schedules First Mirena Lawsuit Hearing
11. Mirena Lawsuits: Bernstein Liebhard LLP Disturbed by New Study Finding IUDs Safe for Teens, In Light of Alleged Mirena Complications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... ... February 26, 2017 , ... This is an ... world’s first to be ISO/IEC 17025:2005 INAB accredited for Der p 1 (house ... is the globally recognised standard that sets out requirements for the technical competence ...
(Date:2/26/2017)... ... February 26, 2017 , ... IndustryArchive.Org . is announcing a new ... B2B Sellers will now only pay for B.A.N.T. quality sales leads based on the ... said, “Given the new reality that B2B buyers are controlling the sales process via ...
(Date:2/26/2017)... ... February 26, 2017 , ... Functional imaging data supports improved ... study released today at the 1st Pan American Parkinson’s and Movement Disorders Congress. ... effective in improving cognitive function in PD patients. This study, led by Ibarretxe-Bilbao ...
(Date:2/24/2017)... ... 24, 2017 , ... HealthPostures, expert standing desk solution designer, ... built into the home office sit stand solution are bold colors, a new ... the benefits embedded in the TaskMate Go are available 24/7 through HealthPostures' online ...
(Date:2/24/2017)... ... February 24, 2017 , ... WHAT: , The New Jersey ... as well as advocacy for the state and region‘s technology businesses, hosted their ... The Council's Innovation Forecast event highlights innovation throughout the region from small to ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... AMSTERDAM , Feb. 27, 2017   ... AEX: PHIA), a global leader in health technology, ... and Drug Administration (FDA) to market its ElastQ ... EPIQ family of ultrasound systems. ElastQ Imaging enables ... stiffness, which is essential for the diagnosis of ...
(Date:2/27/2017)... 27, 2017  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ... company focused on tissue protection, repair and regeneration, ... Co., Ltd., received a positive response from the ... design for RGN-137 to treat epidermolysis bullosa ("EB"). ... incorporates Thymosin beta 4 ("Tß4") as the active ...
(Date:2/27/2017)... 2017  CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: ... M.D., Ph.D., as President and Chief Executive Officer (CEO) and ... Dr. Craig succeeds Richard Love , interim President and ... of Directors.  Dr. Craig has over 20 years of experience ... and Europe . "On behalf ...
Breaking Medicine Technology: